Fundraising Fox
/Companies
Sign in

Viewpoint Molecular Targeting

Coralville, US · Delaware corporation · 1 known investors

Find your way into Viewpoint Molecular Targeting

Sign up to see every warm intro you have to Viewpoint Molecular Targeting

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Viewpoint Molecular Targeting team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Developer of a novel therapeutic for metastatic melanoma (exited).

Biotech

Founders & leadership

FJ
Frances JohnsonCo-founder
MS
Michael SchultzCo-founder
CN
Curtis NelsonNamed on SEC filing
HC
Heyward ColemanNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$15M disclosed across 2 rounds · 2019–2020

▶$14.3MraisedJan 2021 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael SchultzExecutive Officer, Director
  • Curtis NelsonDirector
  • Heyward ColemanExecutive Officer, Director
  • Cameron GrayDirector
  • Frances JohnsonExecutive Officer, Director
Offering amount
$15.8M
Amount sold
$14.3M
Minimum investment
$25K
Sales commissions
$1M
Proceeds to insiders
$500K
Placement agents
National Securities Corporation
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$750KraisedJun 2020 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Curtis NelsonDirector
  • Heyward ColemanExecutive Officer, Director
  • Frances JohnsonExecutive Officer, Director
  • Michael SchultzExecutive Officer, Director
Offering amount
$2M
Amount sold
$750K
Proceeds to insiders
$100K
First sale
Feb 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Viewpoint Molecular Targeting do?
Developer of a novel therapeutic for metastatic melanoma (exited).
Who founded Viewpoint Molecular Targeting?
Viewpoint Molecular Targeting was founded by Frances Johnson, Michael Schultz.
Who are Viewpoint Molecular Targeting's investors?
Viewpoint Molecular Targeting's investors include Next Level Ventures.
How much funding has Viewpoint Molecular Targeting raised?
Viewpoint Molecular Targeting has disclosed $15M raised across 2 rounds.
Where is Viewpoint Molecular Targeting headquartered?
Viewpoint Molecular Targeting is headquartered in Coralville, US.